Overview of current applications and trends in artificial intelligence for cystoscopy and transurethral resection of bladder tumours.
Ikeda A, Nosato H.
Curr Opin Urol. 2024 Jan 1;34(1):27-31. doi: 10.1097/MOU.0000000000001135. Epub 2023 Oct 30.
PMID:37902120
Deep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumors.
Ali N, Bolenz C, Todenhöfer T, Stenzel A, Deetmar P, Kriegmair M, Knoll T, Porubsky S, Hartmann A, Popp J, Kriegmair MC, Bocklitz T.
Sci Rep. 2021 Jun 2;11(1):11629. doi: 10.1038/s41598-021-91081-x.
PMID:34079004
Recurrence of non-muscle invasive bladder carcinoma after transurethral resection with hexaminolevulinate photodynamic diagnosis or regular cystoscopy.
Hoogeveen F, Blanker MH, Cauberg E, Steffens MG.
Scand J Urol. 2023 Dec 6;58:120-125. doi: 10.2340/sju.v58.10160.
PMID:38054524
Letter to the Editor on the systematic review "Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer".
Roupret M, Burger M, Stenzl A.
World J Urol. 2023 Jul;41(7):1997-1999. doi: 10.1007/s00345-023-04435-7. Epub 2023 Jun 13.
PMID:37311989
Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study).
Miyake M, Nishimura N, Inoue T, Suzuki S, Fujii T, Owari T, Hori S, Nakai Y, Toritsuka M, Nakagawa H, Tsukamoto S, Anai S, Torimoto K, Yoneda T, Tanaka N, Fujimoto K.
Trials. 2021 Feb 12;22(1):136. doi: 10.1186/s13063-021-05094-y.